Cross-Sector entity
Of the tracked stories, 2 of 2 also mention Bulk drugs and drug intermediates, the most common co-covered peer. The clearest coverage concentration is economy: 1 of 2 stories, with the rest divided among 1 other category. Surgical products appears in 2 tracked Cross-Sector stories from August 12, 2026.
2 verified stories tracked
Last mentioned: Aug 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 2 of 2 also mention Bulk drugs and drug intermediates, the most common co-covered peer. The clearest coverage concentration is economy: 1 of 2 stories, with the rest divided among 1 other category. Surgical products appears in 2 tracked Cross-Sector stories from August 12, 2026. The tracked stories average 2 original sources each.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Surgical products. Shared-story counts are live from our verified record — not editorial picks.
India's pharma exports grew 6.8% to $8.1B in Q1 FY27, with the US absorbing $2.5B at a 30.89% share — trade and earnings data that shapes the outlook for Indian healthcare exporters and investors.
India's vaccine exports jumped 35.68% to $390M in Q1 FY27 amid $8.1B in total pharma shipments, strengthening the country's role as a supplier of affordable vaccines and generics to global health systems.
Source: moneycontrol.com · calcuttanews.net
